Research news · The Globe and Mail

Adamantane modification anchors structure-defined peptide R&D program

Adamantane modification anchors structure-defined peptide R&D program

The Globe and Mail reported in November 2026 that Uther Peptide has advanced a structure-defined R&D program called Adalank, incorporating an adamantane-modified research sequence.

Source: Uther Peptide Advances Structure-Defined Adalank R&D Program with Adamantane-Modified Research Sequence (The Globe and Mail)

Related in the Skinni library

How Skinni approaches the science

For research use only. This brief summarises a third-party report; it is not a claim about any Skinni product and not medical advice.

More research news

All briefs
Peptide sequence dictates heme-binding bilayer architecture

Research news · Argonne National Laboratory (.gov)

Peptide sequence dictates heme-binding bilayer architecture

Argonne National Laboratory reported in November 2026 that peptide sequence design controls heme-binding bilayer assembly, linking the order of amino acids directly to the structural outcome of the assembled material.

November 3, 2026Read the brief
DOE Expands Designer Peptide Research Possibilities

Research news · Department of Energy (.gov)

DOE Expands Designer Peptide Research Possibilities

Department of Energy (.gov) reported in October 2026 that researchers are developing more designer peptides, opening additional possibilities in peptide science and application.

November 2, 2026Read the brief
Peptide Quality Standards Shift as Development Advances

Research news · Manufacturing Chemist

Peptide Quality Standards Shift as Development Advances

Manufacturing Chemist reported in October 2026 that peptide quality requirements change as a compound moves from research grade through to GMP, with distinct standards applying at each stage of development.

October 22, 2026Read the brief